Delivery Order SPE2DB22D1017-SPE2DB25FYRGG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $13,351.13. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the critical pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for $43,157.04 to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV,...
- The Defense Logistics Agency awarded a $23,458.54 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,351.68 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with a completion date of July 30, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for $33.4K to supply Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for July 29, 2025, and work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $39,414.39 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the...
- The Defense Logistics Agency awarded a $7,383.45 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count packaging) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a ceiling value of $13,405.77. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an...
- The Defense Logistics Agency awarded a $10,678.35 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion on September 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $55,124.14 and an ultimate completion date of August 29, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRGGDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $71,383.15 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, representing part of the company's broader pharmaceutical supply portfolio to federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards consistently reflect its capability to meet federal procurement requirements through open competition across diverse therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.4k | 9/18/25 |